Aptevo Therapeutics Presents New Preclinical Data for APVO436 and ALG.APV-527 at the American Association for Cancer Research 2019 Annual Meeting

    NEXT STORY
    Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
    PREV STORY
    Global Kinetics Corporation Appoints Greg Barrett As Independent Director to its Board of Directors
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BioXcel Therapeutics Announces Initiation of Phase 2 PLACIDITY Trial of BXCL501 for the Treatment of Delirium Related Agitation

    author_avatar
    NASDAQ Market News

    Atara Biotherapeutics Announces Presentations Highlighting Robust Off-the-Shelf, Allogeneic T-Cell Immunotherapy Pipeline and Next-Generation CAR T Technologies at the 60th American Society of Hematology (ASH) Annual Meeting and European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2018

    Moffitt Cancer Center collaborators to present next-generation chimeric antigen receptor T-cell (CAR T) technology ...

    author_avatar
    NASDAQ Market News

    GW Pharmaceuticals to Present at Upcoming Investor Conferences

    - Morgan Stanley 15th Annual Global Healthcare Conference on 13 September -            - Leerink Partners Rare ...

    author_avatar
    NASDAQ Market News